POU5F1 and head and neck squamous cell carcinoma: This report also provides evidence that beyond its prognostic value as a biomarker for patients with HNSCC receiving PORT-C, the involvement of Oct4 in the regulation of the DNA damage response opens new insights into HNSCC radioresistance and stemness and suggests possible strategies for combination treatments with PARP inhibitors.